ALMKT:EPA
Mauna Kea Technologies SA
0,091 €
arrow_downward
−0,98%(−0,00090) 1D
16. nov., 17:03:59 GMT +1 · EUR
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za ALMKT …
Odpri
0,09 €
Visoka
0,09 €
Nizka
0,09 €
Tržna kapitalizacija
18,30 mio.
Povprečni promet
484,45 tis.
Promet
362,25 tis.
Razmerje med ceno delnice in čistim dobičkom
0,78
52-tedenski najvišji tečaj
0,23 €
52-tedenski najnižji tečaj
0,07 €
Čisti dobiček na delnico
0,12 €
Št. izdanih delnic
195,26 mio.
Št. zaposlenih
56
Odpri
0,09 €
Visoka
0,09 €
Nizka
0,09 €
Tržna kapitalizacija
18,30 mio.
Povprečni promet
484,45 tis.
Promet
362,25 tis.
Razmerje med ceno delnice in čistim dobičkom
0,78
52-tedenski najvišji tečaj
0,23 €
52-tedenski najnižji tečaj
0,07 €
Čisti dobiček na delnico
0,12 €
Št. izdanih delnic
195,26 mio.
Št. zaposlenih
56
Novice
Iz spletnih virov in novičarskih partnerjev
ChartMill
·
pred 54 minutami
S&P 500 Gap-Down Movers in Nov. 16, 2026 Session
Benzinga
·
pred 30 minutami
Here’s How Much You Would Have Made Owning iShares S&P 500 Growth ETF Stock In The Last 15 Years
RealMoney Pro
·
pred 58 minutami
Charting the S&P 500: Hanging by a Thread to Bullish Signals
Traders Union
·
pred 55 minutami
Peter Tuchman: S&P 500 loses over $800 billion in market cap
Profil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Vizitka: Mauna Kea Technologies SA
Generalni direktorSacha Loiseau
Št. zaposlenih56
Ustanovljeno2000
Sedež-
SektorHealth Care
Panoga-
Spletno mestomaunakeatech.com